Abstract
Guillain-Barré syndrome (GBS) is an acute demyelinating polyradiculoneuropathy normally associated with a preceding infection, but sometimes it can be linked to a subjacent malignancy. We report an unusual case of GBS occurring as the first clinical manifestation of an esophageal adenocarcinoma in a 65-year-old patient. A GBS neuropathy of undetermined origin may be associated with an underlying tumor and esophageal cancer has to be considered in the differential diagnosis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Willison HJ (2005) The immunobiology of Guillain-Barre syndromes. J Peripher Nerv Syst 10:94–112
Lisak RP, Mitchell M, Zweiman B et al (1977) Guillain-Barre syndrome and Hodgkin’s disease: three cases with immunological studies. Ann Neurol 1:72–78
Halls J, Bredkjaer C, Friis ML (1988) Guillain-Barre syndrome: diagnostic criteria, epidemiology, clinical course, and prognosis. Acta Neurol Scand 78:118–122
Mineo TC, Biancari F, Casciani CU (1995) Polyradiculoneuritis as an initial manifestation of bronchial carcinoma. J Thorac Cardiovasc Surg 109:1254
Swan CH, Wharton BA (1963) Polyneuritis and renal carcinoma. Lancet 2:383–384
Ruhstaller T, Widmer L, Schuller JC et al (2009) Multicenter phase II trial of preoperative induction chemotherapy followed by chemoradiation with docetaxel and cisplatin for locally advanced esophageal carcinoma (SAKK 75/02). Ann Oncol 20:1522–1528
Croft PB, Wilkinson M (1965) The incidence of carcinomatous neuromyopathy in patients with various types of carcinoma. Brain 88:427–434
Forsyth PA, Dalmau J, Graus G et al (1997) Motor neuron syndromes in cancer patients. Ann Neurol 41:722–730
Antoine JC, Mosnier JF, Absi L et al (1999) Carcinoma associated paraneoplastic peripheral neuropathies in patients with and without anti-onconeural antibodies. J Neurol Neurosurg Psychiatry 67:7–14
Re D, Schwenk A, Hegener P et al (2000) Guillain-Barre syndrome in a patient with non-Hodgkin’s lymphoma. Ann Oncol 11:217–220
Tho LM, O’Leary CP, Horrocks I et al (2006) Guillain-Barre syndrome occurring after adjuvant chemo-radiotherapy for endometrial cancer. Gynecol Oncol 100:615–617
Phan TG, Hersch M, Zagami AS (1999) Guillain-Barre syndrome and adenocarcinoma of the gall bladder: a paraneoplastic phenomenon? Muscle Nerve 22:141–142
Mudad R, Hussein A, Peters WP (1995) Guillain-Barre syndrome following autologous bone marrow transplantation. Am J Clin Oncol 18:167–169
Wen PY, Alyea EP, Simon D et al (1997) Guillain-Barre syndrome following allogeneic bone marrow transplantation. Neurology 49:1711–1714
Vigliani MC, Magistrello M, Polo P et al (2004) Risk of cancer in patients with Guillain-Barre syndrome (GBS) A population-based study. J Neurol 251:321–326
Christodoulou C, Anastasopoulos D, Visvikis A et al (2004) Guillain-Barre syndrome in a patient with metastatic colon cancer receiving oxaliplatin-based chemotherapy. Anticancer Drugs 15:997–999
Conflict of interest statement
The authors have no potential conflict of interest.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Zilli, T., Allal, A.S. Guillain-Barré syndrome as an atypical manifestation of an esophageal carcinoma. Neurol Sci 32, 151–153 (2011). https://doi.org/10.1007/s10072-010-0363-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10072-010-0363-9